Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMSP0506BB08 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1673 C82H148N2O32
LMSP0506BA06 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1691.01 C82H150N2O33
LMSP0506BA01 Galalpha1-3Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1550.86 C72H130N2O33
LMSP0506BF08 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1364.89 C70H128N2O23
LMSP0506BB01 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1534.86 C72H130N2O32
LMSP0506BF04 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1310.84 C66H122N2O23
LMSP0506AU08 Galbeta1-4GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1526.94 C76H138N2O28
LMSP0506BF03 Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1282.81 C64H118N2O23
LMSP0506BI08 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1714.03 C84H151N3O32
LMSP0506AV01 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1372.81 C66H120N2O27
LMSP0506BD08 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1323.86 C68H125NO23
LMSP0506AN02 Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1416.83 C68H124N2O28
LMSP0506BB03 Fucalpha1-2Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1590.92 C76H138N2O32
LMSP0506AK02 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1619.91 C76H137N3O33
LMSP0506AV08 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1510.95 C76H138N2O27
LMSP0506AT04 GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1310.84 C66H122N2O23
LMSP0506BH07 Galbeta1-4GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1701.99 C82H147N3O33
LMSP0506BJ04 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1822.03 C86H155N3O37
LMSP0506AM06 Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1732.04 C84H153N3O33
LMSP0506AV02 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1400.84 C68H124N2O27
LMSP0506AP04 Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1310.84 C66H122N2O23
LMSP0506AK08 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1730.02 C84H151N3O33
LMSP0506BD03 Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1241.79 C62H115NO23
LMSP0506AW05 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1646.99 C80H146N2O32
LMSP0506AK01 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1591.88 C74H133N3O33
LMSP0506AI01 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1794.96 C82H146N4O38
LMSP0506AK03 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1647.94 C78H141N3O33
LMSP0506AO01 GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1429.83 C68H123N3O28
LMSP0506AP07 Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1336.86 C68H124N2O23
LMSP0506AV03 Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1428.87 C70H128N2O27
LMSP0506AJ05 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1907.09 C90H162N4O38
LMSP0506AT06 GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1366.91 C70H130N2O23
LMSP0506AH07 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 2108.15 C98H173N5O43
LMSP0506AL01 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1632.91 C76H136N4O33
LMSP0506AJ03 GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1851.02 C86H154N4O38
LMSP0506AW07 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1644.97 C80H144N2O32
LMSP0506AK05 GalNAcbeta1-3Galalpha1-3(Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1704.01 C82H149N3O33
LMSP0506BC06 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1837.07 C88H160N2O37
LMSP0506BC05 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1809.04 C86H156N2O37
LMSP0506AH01 GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3(GalNAcbeta1-4Galbeta1-4GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1998.04 C90H159N5O43
LMSP0506AZ01 Galalpha1-3(Fucalpha1-2)Galbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1169.73 C58H107NO22
LMSP0506BE08 GalNAcbeta1-3Galalpha1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z)) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1526.94 C76H138N2O28
LMSP0506BC04 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1781.01 C84H152N2O37
LMSP0506BC03 Galalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1752.98 C82H148N2O37
LMSP0506BJ02 Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/18:0) Neutral glycosphingolipids [SP05] Galalpha1-3Galbeta1-4Glc- (Isoglobo series) [SP0506] 1765.97 C82H147N3O37
LMSP0507AA06 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/26:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1163.83 C62H117NO18
LMSP0507AA05 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1135.8 C60H113NO18
LMSP0507AA03 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/20:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1079.73 C56H105NO18
LMSP0507AA07 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/24:1(15Z)) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1133.78 C60H111NO18
LMSP0507AA01 Manalpha1-3Manbeta1-4Glcbeta-Cer(d18:1/16:0) Neutral glycosphingolipids [SP05] Manalpha1-3Manbeta1-4Glc- (Mollu series) [SP0507] 1023.67 C52H97NO18